Co-Diagnostics (CODX) Misses Q1 EPS by 406c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($4.06). Revenue for the quarter came in at $150 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
• Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold